WordNet

open to being acted upon in a certain way; "an amenable hospitalization should not result in untimely death"; "the tumor was not amenable to surgical treatment"
disposed or willing to comply; "someone amenable to persuasion" (同)conformable
readily reacting to suggestions and influences; "a responsive student" (同)tractable
liable to answer to a higher authority; "the president is amenable to the constitutional court"
relating to or affected by ischemia (同)ischaemic
a disorder (usually of unknown origin) of the heart muscle (myocardium) (同)myocardiopathy

PrepTutorEJDIC

すなおな,従順な;(…を)すなおに受け入れる《+『to』+『名』》 / 《補語にのみ用いて》(…に)従うべき,責任を負うべき《+『to』+『名』》

Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2016/01/31 00:57:44」(JST)

wiki en

Ischemic cardiomyopathy is a type of cardiomyopathy caused by a narrowing of the coronary arteries which supply blood to the heart.^[1] Typically, patients with ischemic cardiomyopathy have a history of acute myocardial infarction,^[2] however, it may occur in patients with coronary artery disease, but without a past history of acute myocardial infarction. This cardiomyopathy is one of the leading causes of sudden cardiac death.^[3]^[3]

Cause

Atherosclerosis

Ischemic cardiomyopathy is the cause of more than 60% of all systolic heart failures in most countries of the world.^[3]^[4] A chest radiography that demonstrates coronary artery calcification is a probable indication of ischemic cardiomyopathy.^[5]

Among the causes for ischemic cardiomyopathy are:^[6]

Diabetes
Atherosclerosis
Vasospasm
Inflammation of arteries

Pathophysiology

Ischemic cardiomyopathy is caused by a lack of oxygen due to a narrowing of coronary arteries, in turn causing cell death. This can cause different levels of tissue injury and affect large and intermediate arteries alike.^[7]^[8]^[9]

Diagnosis

Ischemic cardiomyopathy can be diagnosed via magnetic resonance imaging (MRI) protocol, imaging both global and regional function. Also the Look-Locker technique is used to identify diffuse fibrosis; it is therefore important to be able to determine the extent of the ischemic scar.^[10] Some argue that only left main- or proximal-left anterior descending artery disease is relevant to the diagnostic criteria for ischemic cardiomyopathy.^[2] Myocardial imaging usually demonstrates left ventricular dilation, severe ventricular disfunction, and multiple infarctions.^[11] Signs include congestive heart failure, angina edema, weight gain and fainting, among others.^[3]^[12]

Management

Play media

Cardiac-Stem-Cells

Revascularization in patients with heart failure and significant coronary artery disease is strongly associated with improved survival, some research showing up to 75% survival rates over 5 years.^[13]^[14] A stem cell study indicated that using autologous cardiac stem cells as a regenerative approach for (after myocardial infarction) the human heart has great potential.^[15]

American Heart Association practice guidelines indicate (ICD) implantable cardioverter-defibrillator use in those with ischemic cardiomyopathy (40 days post-MI) that are (NYHA) New York Heart Association functional class I. LVEF of >30% is often used to differentiate primary from ischemic cardiomyopathy, and a prognosis indicator.^[16]^[17] At the same time, patients who undergo ventricular restoration on top of coronary artery bypass show improved postoperative ejection fraction as compared to those treated with only coronary artery bypass surgery.^[18] Severe cases are treated with heart transplantation.^[19]

Prognosis

One of the most important features differentiating ischemic cardiomyopathy from the other forms of cardiomyopathy is the shortened, or worsened all-cause mortality in patients with ischemic cardiomyopathy. According to several studies, coronary artery bypass graft surgery has a survival advantage over medical therapy (for ischemic cardiomyopathy) across varied follow-ups.^[8]^[20]^[21]^[22]

References

^ "Cardiomyopathy: MedlinePlus Medical Encyclopedia". www.nlm.nih.gov. Retrieved 2015-09-09.
^ ^a ^b Felker, G.Michael; Shaw, Linda K; O’Connor, Christopher M (January 2002). "A standardized definition of ischemic cardiomyopathy for use in clinical research". Journal of the American College of Cardiology 39 (2): 210–218. doi:10.1016/S0735-1097(01)01738-7.
^ ^a ^b ^c ^d Reynolds Delgado (21 April 2009). Interventional Treatment of Advanced Ischemic Heart Disease. Springer Science & Business Media. pp. 39–. ISBN 978-1-84800-395-8.
^ Griffin, Brian P. (2012-10-01). Manual of Cardiovascular Medicine. Lippincott Williams & Wilkins. p. 130. ISBN 9781451131604.
^ Brant, William E.; Helms, Clyde A. (2007-01-01). Fundamentals of Diagnostic Radiology. Lippincott Williams & Wilkins. p. 635. ISBN 9780781761352.
^ Bisognano, John D.; Baker, Marc L.; Earley, Mary Beth (2009-04-09). Manual of Heart Failure Management. Springer Science & Business Media. p. 50. ISBN 9781848821859.
^ Anversa, Piero; Sonnenblick, Edmund H. (1990). "Ischemic cardiomyopathy: Pathophysiologic mechanisms". Progress in Cardiovascular Diseases 33 (1): 49–70. doi:10.1016/0033-0620(90)90039-5. ISSN 0033-0620.
^ ^a ^b Yatteau, Ronald F.; Peter, Robert H.; Behar, Victor S.; Bartel, Alan G.; Rosati, Robert A.; Kong, Yihong (1974). "Ischemic cardiomyopathy: The myopathy of coronary artery disease". The American Journal of Cardiology 34 (5): 520–525. doi:10.1016/0002-9149(74)90121-0. ISSN 0002-9149.
^ Douglas L. Mann; Douglas P. Zipes; Peter Libby; Robert O. Bonow (30 July 2014). Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. Elsevier Health Sciences. pp. 1225–. ISBN 978-0-323-29064-7. Cite uses deprecated parameter |coauthors= (help)
^ Hodler, Jurg (2015). Diseases of the Chest and Heart: Diagnostic Imaging and Interventional. Springer. p. 146. ISBN 978-88-470-5751-7. Retrieved 10 September 2015.
^ E. van der Wall; K.J. Lie (6 December 2012). Recent Views on Hypertrophic Cardiomyopathy. Springer Science & Business Media. pp. 43–. ISBN 978-94-009-4994-2.
^ Allen P. Burke; Fabio Tavora (8 November 2010). Practical Cardiovascular Pathology. Lippincott Williams & Wilkins. pp. 96–. ISBN 978-1-60547-841-8.
^ Luciani, Giovanni Battista; Montalbano, Giuseppe; Casali, Gianluca; Mazzucco, Alessandro (2000). "Predicting long-term functional results after myocardial revascularization in ischemic cardiomyopathy". The Journal of Thoracic and Cardiovascular Surgery 120 (3): 478–489. doi:10.1067/mtc.2000.108692. ISSN 0022-5223.
^ Falk, Erling; Shah, Prediman; Feyter, Pim de (2007-03-28). Ischemic Heart Disease. CRC Press. p. 226. ISBN 9781840765151.
^ Cai, Lu; Keller, Bradley B (2014-01-03). "Cardiac regeneration and diabetes". Regenerative Medicine Research 2 (1). doi:10.1186/2050-490X-2-1. ISSN 2050-490X. PMC 4422323. PMID 25984329.
^ Iskandrian, Abdulmassih S.; Helfeld, Hope; Lemlek, Joseph; Lee, Jaetae; Iskandrian, Basil; Heo, Jaekyeong (1992). "Differentiation between primary dilated cardiomyopathy and ischemic cardiomyopathy based on right ventricular performance". American Heart Journal 123 (3): 768–773. doi:10.1016/0002-8703(92)90518-Z. ISSN 0002-8703.
^ Hunt, S. A. (20 September 2005). "ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult--Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): Developed in Collaboration With the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: Endorsed by the Heart Rhythm Society". Circulation 112 (12): 1825–1852. doi:10.1161/CIRCULATIONAHA.105.167587. Retrieved 10 September 2015.
^ Maxey, Thomas S; Reece, T.Brett; Ellman, Peter I; Butler, Paris D; Kern, John A; Tribble, Curtis G; Kron, Irving L (2004). "Coronary artery bypass with ventricular restoration is superior to coronary artery bypass alone in patients with ischemic cardiomyopathy". The Journal of Thoracic and Cardiovascular Surgery 127 (2): 428–434. doi:10.1016/j.jtcvs.2003.09.024. ISSN 0022-5223. PMID 14762351.
^ H. W. Louie, H. Laks, E. Milgalter, D. C. Jr Drinkwater, M. A. Hamilton, R. C. Brunken & L. W. Stevenson (November 1991). "Ischemic cardiomyopathy. Criteria for coronary revascularization and cardiac transplantation". Circulation 84 (5 Suppl): III290–III295. PMID 1934422.
^ O’Connor, Christopher M; Velazquez, Eric J; Gardner, Laura H; Smith, Peter K; Newman, Mark F; Landolfo, Kevin P; Lee, Kerry L; Califf, Robert M; Jones, Robert H (2002). "Comparison of coronary artery bypass grafting versus medical therapy on long-term outcome in patients with ischemic cardiomyopathy (a 25-year experience from the Duke Cardiovascular Disease Databank)". The American Journal of Cardiology 90 (2): 101–107. doi:10.1016/S0002-9149(02)02429-3. ISSN 0002-9149.
^ Velazquez, Eric J.; Williams, Judson B.; Yow, Eric; Shaw, Linda K.; Lee, Kerry L.; Phillips, Harry R.; O’Connor, Christopher M.; K.Smith, Peter; Jones, Robert H. (2012-02-01). "Long-term Survival of Patients with Ischemic Cardiomyopathy Treated by CABG versus Medical Therapy". The Annals of thoracic surgery 93 (2): 523–530. doi:10.1016/j.athoracsur.2011.10.064. ISSN 0003-4975. PMC 3638256. PMID 22269720.
^ Elefteriades, John A; Morales, David L.S; Gradel, Christophe; Tollis, George; Levi, Evelyn; Zaret, Barry L (1997). "Results of Coronary Artery Bypass Grafting by a Single Surgeon Patients With Left Ventricular Ejection Fractions ≤30%". The American Journal of Cardiology 79 (12): 1573–1578. doi:10.1016/S0002-9149(97)00201-4. ISSN 0002-9149.

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. Ischemic cardiomyopathy: Treatment and prognosis
2. 心不全の疫学および原因 epidemiology and causes of heart failure
3. 心不全および心筋症における心臓突然死の一次予防 primary prevention of sudden cardiac death in heart failure and cardiomyopathy
4. 心不全および心筋症における心突然死の二次予防 secondary prevention of sudden cardiac death in heart failure and cardiomyopathy
5. 拡張型心筋症の原因 causes of dilated cardiomyopathy

English Journal

The effect of a peptide-modified thermo-reversible methylcellulose on wound healing and LV function in a chronic myocardial infarction rodent model.

Mihardja SS, Gonzales JA, Gao D, Sievers RE, Fang Q, Stillson CA, Yu J, Peng M, Lee RJ.SourceCardiovascular Research Institute, University of California San Francisco, San Francisco, CA 94143, USA.
Biomaterials.Biomaterials.2013 Nov;34(35):8869-77. doi: 10.1016/j.biomaterials.2013.07.028. Epub 2013 Jul 26.
Myocardial infarction is the main contributor to heart failure. In this study we examined whether modification of a thermo-reversible cellulose-based polymer with extracellular-matrix derived functional groups could promote wound healing and improve cardiac function in a chronic rodent model of isch
PMID 23895998

Mechanics of the mitral annulus in chronic ischemic cardiomyopathy.

Rausch MK, Tibayan FA, Ingels NB Jr, Miller DC, Kuhl E.SourceDepartment of Mechanical Engineering, Stanford University, 496 Lomita Mall, Stanford, CA, 94305, USA, mkrausch@stanford.edu.
Annals of biomedical engineering.Ann Biomed Eng.2013 Oct;41(10):2171-80. doi: 10.1007/s10439-013-0813-7. Epub 2013 May 1.
Approximately one third of all patients undergoing open-heart surgery for repair of ischemic mitral regurgitation present with residual and recurrent mitral valve leakage upon follow up. A fundamental quantitative understanding of mitral valve remodeling following myocardial infarction may hold the
PMID 23636575

Changes in parasympathetic system in medulla oblongata in male pigs in the course of tachycardia-induced cardiomyopathy.

Tomaszek A, Kiczak L, Bania J, Krupa P, Pasławska U, Zacharski M, Janiszewski A, Stefaniak T, Zyśko D, Ardehali H, Jankowska EA, Ponikowski P.SourceRegional Specialist Hospital in Wroclaw, Research and Development Centre, Wroclaw, Poland; Department of Heart Diseases, Wroclaw Medical University, Wroclaw, Poland.
Autonomic neuroscience : basic & clinical.Auton Neurosci.2013 Oct;177(2):253-9. doi: 10.1016/j.autneu.2013.05.010. Epub 2013 Jul 23.
BACKGROUND: Autonomic imbalance constituting a fundamental feature of heart failure (HF) has been assessed mainly at the periphery. Changes in the functioning of autonomic centers in the brain remain unclear. We investigated the molecular elements of parasympathetic system, i.e. α7 nicotinic acetyl
PMID 23891249

Japanese Journal

難治性重症虚血性心筋症に対して左室形成術と冠動脈バイパス術が著効した1例

田辺彩夏,清水信行,前澤秀之 [他],前田敦雄,森敬善,若月大輔,浅野冬樹,下島桐,佐藤督忠,江波戸美緒,東祐圭,鈴木洋,礒良崇,嶽山陽一,野口権一郎,田中弘之
日本心臓病学会誌 =Journal of cardiology. Japanese edition 7(3), 213-219, 2012-10-15
NAID 10031122218

Impact of Functional, Morphological and Clinical Parameters on Epicardial Adipose Tissue in Patients With Coronary Artery Disease

DOESCH Christina,HAGHI Dariusch,SUSELBECK Tim,SCHOENBERG Stefan O.,BORGGREFE Martin,PAPAVASSILIU Theano
Circulation journal : official journal of the Japanese Circulation Society 76(10), 2426-2434, 2012-09-25
… Thus, different amounts of EAT reflect different stages of CAD underlining the complex interaction of EAT in the pathogenesis and progression of ischemic cardiomyopathy. (Circ J 2012; …
NAID 10030874987

Role of Imaging in Ablation Therapy of Ventricular Arrhythmias : Focus on Cardiac Magnetic Resonance Imaging

YOKOKAWA Miki,MUELLER Gisela,BOGUN Frank
Circulation journal : official journal of the Japanese Circulation Society 76(6), 1292-1298, 2012-05-25
… In this article, we will discuss the role of MRI in diagnosing different forms of non-ischemic cardiomyopathy and its role in risk stratification. …
NAID 10030315609

Related Pictures

Cardiomyopathies; Myocardial Diseases; Myocardial Diseases, Primary; Myocardial Ischemic Cardiomyopathy. Causes, symptoms, treatment Ischemic Cardiomyopathy Ischemic Cardiomyopathy: Symptoms, Causes, & Treatment Ischemic Cardiomyopathy: Typical Symptoms, Who's At Risk, And 5 Tips To Prevent It How to treat ischemic cardiomyopathy? Causes, symptoms, and prognosis Ischemic Cardiomyopathy - Cardiology - Highland Hospital - University of Rochester Ischemic Cardiomyopathy | Cardiology | HealthSoul

★リンクテーブル★

リンク元	「虚血性心筋症」「amenable」「慢性虚血性心疾患」「ischaemic cardiomyopathy」
関連記事	「ischemic」

「虚血性心筋症」

Ischemic Cardiomyopathy
Classification and external resources
ICD-10	I25.5
	[edit on Wikidata]

　　[★]

英: ischemic cardiomyopathy
関: 心筋症、拡張型心筋症

治療

参考1

二次予防：アスピリンやスタチンの服用、高血圧と糖尿病の管理、禁煙、運動療法
薬物療法：(禁忌でない限り全ての患者に行う)ACE阻害薬、βブロッカー、ループ利尿薬
デバイス療法：適応がある患者で薬物療法に加えて実施

埋め込み式除細動器
両心室ペーシングによる心臓細動器療法。

左室形成術：左室の奇異運動、無運動に対して行われる。虚血心筋症患者にCABG単独群とCABG＋左室形成術を行った群では予後に差がなかったというRCTがある(参考1)。
血行再建：休眠心筋細胞のreactivation
幹細胞/自己筋細胞移植

参考

1. [charged] Diagnosis and management of ischemic cardiomyopathy - uptodate [1]

「amenable」

　　[★]

adj.

受け入れられる

Despite these theoretical benefits, a randomized trial of 1000 patients with ischemic cardiomyopathy and an anterior akinetic or dyskinetic region of myocardium amenable to ventricular reconstruction found that the addition of left ventricular reconstruction to CABG did not improve outcomes compared to CABG alone.

関: acceptable

「慢性虚血性心疾患」

　　[★]

英: chronic ischemic heart disease
関: 虚血性心疾患

Chronic IHD, also called ischemic cardiomyopathy
progressive development of congestive heart failure without chest pain defines chronic ischemic heart disease, which is usually due to involvement of all three coronary branches and associated with diffuse loss of myofibers and fibrosis throughout the ventricles. (Q book p.299)

「ischaemic cardiomyopathy」

　　[★]

虚血性心筋症

関: ischemic cardiomyopathy

「ischemic」

　　[★]

adj.

虚血性の、虚血の、虚血下の、乏血の

関: ischaemia、ischaemic、ischemia、oligemia

[1] "Cardiomyopathy: MedlinePlus Medical Encyclopedia". www.nlm.nih.gov. Retrieved 2015-09-09.

[MICHAEL2002-2] Felker, G.Michael; Shaw, Linda K; O’Connor, Christopher M (January 2002). "A standardized definition of ischemic cardiomyopathy for use in clinical research". Journal of the American College of Cardiology 39 (2): 210–218. doi:10.1016/S0735-1097(01)01738-7.

[Delgado2009-3] Reynolds Delgado (21 April 2009). Interventional Treatment of Advanced Ischemic Heart Disease. Springer Science & Business Media. pp. 39–. ISBN 978-1-84800-395-8.

[4] Griffin, Brian P. (2012-10-01). Manual of Cardiovascular Medicine. Lippincott Williams & Wilkins. p. 130. ISBN 9781451131604.

[5] Brant, William E.; Helms, Clyde A. (2007-01-01). Fundamentals of Diagnostic Radiology. Lippincott Williams & Wilkins. p. 635. ISBN 9780781761352.

[6] Bisognano, John D.; Baker, Marc L.; Earley, Mary Beth (2009-04-09). Manual of Heart Failure Management. Springer Science & Business Media. p. 50. ISBN 9781848821859.

[AnversaSonnenblick1990-7] Anversa, Piero; Sonnenblick, Edmund H. (1990). "Ischemic cardiomyopathy: Pathophysiologic mechanisms". Progress in Cardiovascular Diseases 33 (1): 49–70. doi:10.1016/0033-0620(90)90039-5. ISSN 0033-0620.

[YatteauPeter1974-8] Yatteau, Ronald F.; Peter, Robert H.; Behar, Victor S.; Bartel, Alan G.; Rosati, Robert A.; Kong, Yihong (1974). "Ischemic cardiomyopathy: The myopathy of coronary artery disease". The American Journal of Cardiology 34 (5): 520–525. doi:10.1016/0002-9149(74)90121-0. ISSN 0002-9149.

[MannZipes2014-9] Douglas L. Mann; Douglas P. Zipes; Peter Libby; Robert O. Bonow (30 July 2014). Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. Elsevier Health Sciences. pp. 1225–. ISBN 978-0-323-29064-7. Cite uses deprecated parameter |coauthors= (help)

[10] Hodler, Jurg (2015). Diseases of the Chest and Heart: Diagnostic Imaging and Interventional. Springer. p. 146. ISBN 978-88-470-5751-7. Retrieved 10 September 2015.

[WallLie2012-11] E. van der Wall; K.J. Lie (6 December 2012). Recent Views on Hypertrophic Cardiomyopathy. Springer Science & Business Media. pp. 43–. ISBN 978-94-009-4994-2.

[BurkeTavora2010-12] Allen P. Burke; Fabio Tavora (8 November 2010). Practical Cardiovascular Pathology. Lippincott Williams & Wilkins. pp. 96–. ISBN 978-1-60547-841-8.

[LucianiMontalbano2000-13] Luciani, Giovanni Battista; Montalbano, Giuseppe; Casali, Gianluca; Mazzucco, Alessandro (2000). "Predicting long-term functional results after myocardial revascularization in ischemic cardiomyopathy". The Journal of Thoracic and Cardiovascular Surgery 120 (3): 478–489. doi:10.1067/mtc.2000.108692. ISSN 0022-5223.

[14] Falk, Erling; Shah, Prediman; Feyter, Pim de (2007-03-28). Ischemic Heart Disease. CRC Press. p. 226. ISBN 9781840765151.

[15] Cai, Lu; Keller, Bradley B (2014-01-03). "Cardiac regeneration and diabetes". Regenerative Medicine Research 2 (1). doi:10.1186/2050-490X-2-1. ISSN 2050-490X. PMC 4422323. PMID 25984329.

[IskandrianHelfeld1992-16] Iskandrian, Abdulmassih S.; Helfeld, Hope; Lemlek, Joseph; Lee, Jaetae; Iskandrian, Basil; Heo, Jaekyeong (1992). "Differentiation between primary dilated cardiomyopathy and ischemic cardiomyopathy based on right ventricular performance". American Heart Journal 123 (3): 768–773. doi:10.1016/0002-8703(92)90518-Z. ISSN 0002-8703.

[17] Hunt, S. A. (20 September 2005). "ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult--Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): Developed in Collaboration With the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: Endorsed by the Heart Rhythm Society". Circulation 112 (12): 1825–1852. doi:10.1161/CIRCULATIONAHA.105.167587. Retrieved 10 September 2015.

[MaxeyReece2004-18] Maxey, Thomas S; Reece, T.Brett; Ellman, Peter I; Butler, Paris D; Kern, John A; Tribble, Curtis G; Kron, Irving L (2004). "Coronary artery bypass with ventricular restoration is superior to coronary artery bypass alone in patients with ischemic cardiomyopathy". The Journal of Thoracic and Cardiovascular Surgery 127 (2): 428–434. doi:10.1016/j.jtcvs.2003.09.024. ISSN 0022-5223. PMID 14762351.

[19] H. W. Louie, H. Laks, E. Milgalter, D. C. Jr Drinkwater, M. A. Hamilton, R. C. Brunken & L. W. Stevenson (November 1991). "Ischemic cardiomyopathy. Criteria for coronary revascularization and cardiac transplantation". Circulation 84 (5 Suppl): III290–III295. PMID 1934422.

[O.E2.80.99ConnorVelazquez2002-20] O’Connor, Christopher M; Velazquez, Eric J; Gardner, Laura H; Smith, Peter K; Newman, Mark F; Landolfo, Kevin P; Lee, Kerry L; Califf, Robert M; Jones, Robert H (2002). "Comparison of coronary artery bypass grafting versus medical therapy on long-term outcome in patients with ischemic cardiomyopathy (a 25-year experience from the Duke Cardiovascular Disease Databank)". The American Journal of Cardiology 90 (2): 101–107. doi:10.1016/S0002-9149(02)02429-3. ISSN 0002-9149.

[21] Velazquez, Eric J.; Williams, Judson B.; Yow, Eric; Shaw, Linda K.; Lee, Kerry L.; Phillips, Harry R.; O’Connor, Christopher M.; K.Smith, Peter; Jones, Robert H. (2012-02-01). "Long-term Survival of Patients with Ischemic Cardiomyopathy Treated by CABG versus Medical Therapy". The Annals of thoracic surgery 93 (2): 523–530. doi:10.1016/j.athoracsur.2011.10.064. ISSN 0003-4975. PMC 3638256. PMID 22269720.

[ElefteriadesMorales1997-22] Elefteriades, John A; Morales, David L.S; Gradel, Christophe; Tollis, George; Levi, Evelyn; Zaret, Barry L (1997). "Results of Coronary Artery Bypass Grafting by a Single Surgeon Patients With Left Ventricular Ejection Fractions ≤30%". The American Journal of Cardiology 79 (12): 1573–1578. doi:10.1016/S0002-9149(97)00201-4. ISSN 0002-9149.

匿名

検索

案内

案内

ischemic cardiomyopathy